Longitudinal Access and Adjudication Data (LAAD) integrates IQVIA’s prescription, lifecycle, medical, and remittance claims into a single, de-identified, patient-level transactional dataset. By connecting these data sources, LAAD enables pharmaceutical manufacturers, select digital health companies, academia, medtech organizations, and financial institutions to gain a comprehensive, patient-centric longitudinal view of healthcare utilization and access.

By consolidating pharmacy, medical, and financial claim events, LAAD supports deeper analysis of patient access, healthcare utilization, treatment outcomes, market access performance, financial burden, treatment dynamics, and competitive landscapes. Organizations can use these insights to better understand patient journeys, identify barriers to access, and make more informed strategic decisions.

Download the full product description to learn how LAAD delivers a connected view of healthcare experiences and access across the patient journey. Explore the dataset’s capabilities, use cases, and strategic applications to unlock deeper insights and drive more confident decision-making.